Clinical relevance and indications for cardiac magnetic resonance imaging 2013: An interdisciplinary expert statement;Klinischer Stellenwert und Indikationen zur Magnetresonanztomografie des Herzens 2013: Ein interdisziplinäres Expertenstatement

RoFo Fortschritte auf dem Gebiet der Rontgenstrahlen und der Bildgebenden Verfahren

Volumn 185, Issue 3, 2013, Pages 209-218

  Hergan, K ^a   Globits, S ^b   Schuchlenz, H ^c   Kaiser, B ^d   Fiegl, N ^e   Artmann, A ^f   Hawlisch, K ^e   Newrkla, S ^e   Gessner, M ^g   Bernt, R ^g   Schuler, J ^h   Friedrich, G ⁱ   Trieb, T ^j   Wolf, F ^j   Reiter, G ^k   Sorantin, E ^j   Loewe, C ^j   Gamillscheg, A ^k  

^a Univ Klinik für Innere Medizin i   (Austria)

^b Herz Kreislauf Zentrum Groß Gerungs   (Austria)

^c UNIVERSITY HOSPITAL GRAZ   (Austria)

^d DZU   (Austria)

^e KH Hietzing Wien ^*  (Austria)

^f Radiologisches Institut   (Austria)

^g HANUSCH HOSPITAL   (Austria)

^h PARACELSUS MEDICAL UNIVERSITY   (Austria)

ⁱ INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^j UNIV KLIN FÜR RADIODIAGNOSTIK   (Austria)

^k SIEMENS AG ÖSTERREICH   (Austria)

more..

Author keywords

cardiac; heart; MR imaging

Indexed keywords

ARTICLE; CARDIOLOGIST; CARDIOVASCULAR MAGNETIC RESONANCE; CLINICAL PRACTICE; HEART DISEASE; HUMAN; PRIORITY JOURNAL; RADIOLOGIST;

COOPERATIVE BEHAVIOR; CORONARY DISEASE; HEART DISEASES; HUMANS; IMAGE ENHANCEMENT; IMAGE INTERPRETATION, COMPUTER-ASSISTED; INTERDISCIPLINARY COMMUNICATION; MAGNETIC RESONANCE ANGIOGRAPHY; MAGNETIC RESONANCE IMAGING; MYOCARDIAL PERFUSION IMAGING; SENSITIVITY AND SPECIFICITY;

EID: 84874208379     PISSN: 14389029     EISSN: 14389010     Source Type: Journal    
DOI: 10.1055/s-0032-1330763     Document Type: Article

References (92)

1. Achenbach S., Barkhausen J., Beer M. et al. Konsensusempfehlungen der DRG/DGK/DGPK zum Einsatz der Herzbildgebung mit Computertomografie und Magnetresonanztomografie. Fortschr Röntgenstr: 2012; 184 345 368
2. Hergan K., Globits S., Loewe C. et al. Aktueller Stellenwert der MSCTA in der Koronargefassdiagnostik (2011): Klinischer Leitfaden der Osterreichischen Gesellschaften fur Kardiologie und Radiologie. Fortschr Röntgenstr: 2011; 183 964 971
3. Lotz J., Kivelitz D., Fischbach R. et al. Empfehlungen für den Einsatz der Computertomografie und Magnetresonanztomografie in der Herzdiagnostik. Teil 2 - Magnetresonanztomografie. Fortschr Röntgenstr: 2009; 181 800 814
4. Pennell D. J., Sechtem U. P., Higgins C. B. et al. Clinical indications for cardiovascular magnetic resonance (CMR): Consensus Panel report. Eur Heart J: 2004; 25 1940 1965 (Pubitemid 39452612)
5. de Jong M. C., Genders T. SS, van Geuns R. J. et al. Diagnostic performance of stress myocardial perfusion imaging for coronary artery disease: a systemic review and meta-analysis. Eur Radiol (electronically published) 10.1007/s00330-012-2434-1
6. Nandalur K. R., Dwamena B. A., Choudhri A. F. et al. Diagnostic performance of stress cardiac magnetic resonance imaging in the detection of coronary artery disease. J Am Coll Cardiol: 2007; 50 1343 1353 (Pubitemid 47449733)
7. Schwitter J., Wacker C. M., Wilke N. et al. MR-IMPACT II: Magnetic resonance imaging for myocardial perfusion assessment in coronary artery disease trial: perfusion-cardiac magnetic resonance vs. single-photon emission computed tomography for the detection of coronary artery disease: a comparative multicentre, multivendor trial. Eur Heart J: 2012; (first published online March 4, 2012)
8. Greenwood J. P., Maredia N., Younger J. F. et al. Cardiovascular magnetic resonance imaging and single-photon emission computed tomography for diagnosis of coronary heart disease (CE-MARK): a prospective trial. Lancet: 2012; 379 453 460
9. Watkins S., McGeoch R., Lyne J. et al. Validation of Magnetic Resonance Myocardial Perfusion Imaging With Fractional Flow Reserve for the Detection of Significant Coronary Heart Disease. Circulation: 2009; 120 2207 2213
10. Chung S. Y., Lee K. Y., Chun E. J. et al. Comparison of stress perfusion MRI and SPECT for detection of myocardial ischemia in patients with angiographically proven threevessel coronary artery disease. Am J Roentgenol: 2010; 195 356 362
11. Klug G., Mayr A., Schenk S. et al. Prognostic value at 5 years of microvascular obstruction after acute myocardial infarction assessed by cardiovascular magnetic resonance. J Cardiovasc Magn Reson: 2012; 14 46
12. Grothues F., Smith G. C., Moon J. C. et al. Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy. Am J Cardiol: 2002; 90 29 34 (Pubitemid 34671198)
13. Cerqueira M. D., Weissman N. J., Dilsizian V. et al. Standardized Myocardial Segmentation and Nomenclature for Tomographic Imaging of the Heart: A Statement for Healthcare Proffessionals From the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation: 2002; 105 539 542 (Pubitemid 34262671)
14. Allman K. C., Shaw L. J., Hachamovitch R. et al. Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. J Am Coll Cardiol: 2002; 39 1151 1158 (Pubitemid 34267418)
15. Kim R. J., Wu E., Rafael A. et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med: 2000; 343 1445 1453
16. Wellnhofer E., Olariu A., Klein C. et al. Magnetic resonance low-dose dobutamine test is superior to scar quantification for the prediction of functional recovery. Circulation: 2004; 109 2172 2174 (Pubitemid 38625392)
17. Kim R. J., Manning W. J. Viability assessment by delayed enhancement cardiovascular magnetic resonance imaging: will low-dose dobutamine dull the shine? Circulation: 2004; 109 2476 2479 (Pubitemid 38720542)
18. White J. A., Yee R., Yuan X. et al. Delayed enhancement magnetic resonance imaging predicts response to cardiac resynchronization therapy in patients with intraventricular dyssynchrony. J Am Coll Cardiol: 2006; 48 1953 1960 (Pubitemid 44738444)
19. Chalil S., Foley P., Muyhaldeen S. et al. Late gadolinium enhancement-cardiovascular magnetic resonance as a predictor of response to cardiac resynchronization therapy in patients with ischaemic cardiomyopathy. Europace: 2007; 9 1031 1037 (Pubitemid 351773274)
20. Maron B. J., Towbin J. A., Thiene G. et al. Contemporary definitions and classification of the cardiomyopathies. A scientific statement of the American Heart Association. Circulation: 2006; 113 1807 1816
21. Karamitsos T. D., Francis J. M., Myerson S. The role of cardiovascular magnetic resonance imaging in heart failure. J Am Coll Cardiol: 2009; 54 1407 1424
22. Nathan M., Chia Y. L., Croisille P. et al. Assessment of Myocardial Fibrosis With Cardiovascular Magnetic Resonance. J Am Coll Cardiol: 2011; 57 891 903
23. Leyva F. Cardiac resynchronization therapy guided by cardiovascular magnetic resonance. J Cardiovasc Magn Reson: 2010; 12 64 86
24. Leyva F., Foley P. W., Chalil S. et al. Cardiac resynchronisation therapy guided by late gadolinium-enhancement cardiovascular magnetic resonance. J Cardiovasc Magn Reson: 2011; 13 29 38
25. Pankuweit S., Richter A., Ruppert V. et al. Classification of cardiomyopathies and indication for endomyocardial biopsy revisited. Herz: 2009; 34 55 62
26. Elliott P., Andersson B., Arbustini E. et al. Classification of the cardiomyopathies: a position statement from the european society of cardiology working group on myocardial and pericardial diseases. Eur Heart J: 2008; 29 270 276
27. McCrohon J. A., Moon J. C., Prasad S. K. et al. Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium enhanced cardiovascular magnetic resonance. Circulation: 2003; 108 54 59 (Pubitemid 36859020)
28. Gersh B. J., Maron B. J., Bonow R. O. et al. 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines developed in collaboration with the American Association for Thoracic Surgery, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol: 2011; 58 2703 2738
29. White J. A., Fine N. M., Gula L. et al. Utility of cardiovascular magnetic resonance in identifying substrate for malignant ventricular arrhythmias. Circ Cardiovasc Imaging: 2012; 5 12 20
30. Jenni R., Oechslin E., Schneider J. et al. Echocardiographic and pathoanatomical characteristics of isolated left ventricular noncompaction: a step towards classification as a distinct cardiomyopathy. Heart: 2001; 86 666 671 (Pubitemid 33086886)
31. Petersen S. E., Selvanayagam J. B., Wiesmann F. Left Ventricular Non-Compaction: Insights From Cardiovascular Magnetic Resonance Imaging. J Am Coll Cardiol: 2005; 46 101 105 (Pubitemid 40905136)
32. Dursun M., Agayev A., Ertugrul T. et al. MR imaging features of ventricular noncompaction: Emphasis on distribution and pattern of fibrosis. Eur J Radiol: 2010; 74 147 151
33. Fernández-Pérez G. C., Anguilar-Arjona J. A., Tardáguilla de la Fuente G. et al. Takotsubo cardiomyopathy: Assessment with cardiac MRI. Am J Roentgenol: 2010; 195 W139 W145
34. Sharkey S. W., Windenburg D. C., Lesser J. R. et al. Natural History and Expansive Clinical Profile of Stress (Tako-Tsubo) Cardiomyopathy. J Am Coll Cardiol: 2010; 55 333 341
35. Masui T., Finck S., Higgins C. B. Constrictive pericarditis and restrictive cardiomyopathy: evaluation with MR imaging. Radiology: 1992; 182 369 373
36. Mahrholdt H., Wagner A., Judd R. M. et al. Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies. Eur Heart J: 2005; 26 1461 1474 (Pubitemid 41373486)
37. Cheng H., Zhao S., Jiang S. et al. The relative atrial volume ratio and late gadolinium enhancement provide additive information to differentiate constrictive pericarditis from restrictive cardiomyopathy. J Cardiovasc Magn Reson: 2011; 13 15 23
38. Breuckmann F., Maderwald S., Buhr C. et al. Cardiac MRI: estimation of changes in normalized myocardial gadolinium accumulation over time after contrast injection in patients with acute myocarditis and healthy volunteers. Fortschr Röntgenstr: 2011; 183 933 938
39. Friedrich M. G., Sechtem U., Schulz-Menger J. et al. Cardiovascular Magnetic Resonance in Myocarditis: A JACC White Paper. J Am Coll Cardiol: 2009; 53 1475 1487
40. Frank H., Globits S. Magnetic Resonance Imaging evaluation of myocardial and pericardial disease. JMRI: 1999; 10 617 626 (Pubitemid 29519763)
41. Laissy J. P., Hyafil F., Juliard J. M. et al. Differentiating acute myocardial infarction from Myocarditis: Diagnostic value of early- and delayed-perfusion cardiac MR imaging. Radiology: 2005; 237 75 82 (Pubitemid 41346148)
42. Goitein O., Matetzky S., Beinart R. et al. Acute myocarditis: non-invasive evaluation with cardiac MRI and transthoracic echocardiography. Am J Roentgenol: 2008; 192 254 258
43. Gahide G., Bertrand D., Roubille F. et al. MR delayed enhancement imaging findings in suspected acute myocarditis. Eur Radiol: 2010; 20 65 72
44. Gutberlet M., Spors B., Thoma T. et al. Suspected chronic myocarditis at cardiac CT: diagnostic accuracy and association with immunohistological detected inflammation and viral persistence. Radiology: 2008; 246 401 409
45. Yilmaz A., Kindermann I., Kindermann M. et al. Comparative evaluation of left and right ventricular endomyocardial biopsy: differences in complication rate and diagnostic performance. Circulation: 2010; 122 900 909
46. Mahrhold H., Goedecke C., Wagner A. et al. Cardiovascular magnetic resonance assessment of human myocarditis: a comparison to histology and molecular pathology. Circulation: 2004; 109 1250 1258 (Pubitemid 38379570)
47. Keller D., Osswald S., Bremerich J. Arrhythmogenic rightventricular dysplasia: diagnostic and prognostic value of cardiac MRI in relation to arrhythmia free survival. Int J Card Imaging: 2003; 19 537 543 (Pubitemid 37521330)
48. Kayser H. W., van der Wall E. E., Sivananthan M. U. et al. Diagnosis of arrhythmogenic right ventricular dysplasie: a review. Radiographics: 2002; 22 639 648
49. Marcus F. I., Zareba W., Calkins H. et al. Arrhytmogenic right ventricular cardiomyopathy/dysplasia clinical presentation and diagnostic evaluation: results from the North American Multidisciplinary Study. Heart Rhythm: 2009; 6 984 992
50. Bluemke D. A., Krupinski E. A., Ovitt T. et al. MRI Imaging of arrhythmogenic right ventricular cardiomyopathy: morphological findings and intraobserver reliability. Cardiology: 2003; 99 153 612
51. Marcus F. I., McKenna W. J., Sherrill D. et al. Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the task force criteria. Circulation: 2010; 121 1533 1541
52. Globits S., Kreiner G., Frank H. et al. Significance of morphological abnormalities detected by MRI in patients undergoing successful ablation of right ventricular outflow tract tachycardia. Circulation: 1997; 96 2633 2640 (Pubitemid 27451356)
53. Wang Z. J., Reddy G. P., Gotway M. B. et al. CT and MR imaging of pericardial disease. Radiographics: 2003; 23 S167 S180 (Pubitemid 38037242)
54. Masui T., Finck S., Higgins C. B. Constrictive pericarditis and restrictive cardiomyopathy: evaluation with MR imaging. Radiology: 1992; 182 369 373
55. Sechtem U., Tscholakoff D., Higgins C. B. MRI of the abnormal pericardium. Am J Roentgenol: 1986; 147 239 244
56. Lam K. Y., Dickens P., Chan A. C. Tumors of the heart. A 20-year experience with a review of 12,485 consecutive autopsies. Arch Pathol Lab Med: 1993; 117 1027 1031 (Pubitemid 23292033)
57. Hoffmann U., Globits S., Schima W. et al. Usefulness of magnetic resonance imaging of cardiac and paracardiac masses. Am J Cardiol: 2003; 92 890 895 (Pubitemid 37163597)
58. Aurigemma G., Reichek N., Schiebler M. et al. Evaluation of aortic regurgitation by cardiac cine MRI: planar analysis and comparison to Doppler echocardiography. Cardiology: 1991; 78 340 347
59. Wagner S., Auffermann W., Buser P. et al. Diagnostic accuracy and estimation of the severity of valvular regurgitation from the signal void on cine magnetic resonance imaging. Am Heart J: 1989; 118 760 767 (Pubitemid 19242573)
60. Glockner J. F., Johnston D. L., McGee K. P. Evaluation of cardiac valvular disease with MR imaging: Qualitative and quantitative techniques. Radiographics: 2003; 23 e9
61. Nishimura F. Oblique cine MRI for the evaluation of aortic regurgitation: comparison with cineangiography. Clin Cardiol: 1992; 15 73 78
62. Globits S., Frank F., Mayr H. et al. Quantitative assessment of aortic regurgitation by magnetic resonance imaging. Eur Heart J 1992 13 78 83
63. Sondergaard L., Lindvig K., Hildebrandt P. et al. Quantification of aortic regurgitation by magnetic resonance velocity mapping. Am Heart J: 1993; 125 1081 1090 (Pubitemid 23117341)
64. Fujita N., Chazouilleres A. F., Hartiala J. J. et al. Quantification of mitral regurgitation by velocity-encoded cine nuclear magnetic resonance imaging. J Am Coll Cardiol: 1994; 23 951 958 (Pubitemid 24090882)
65. Morris M. F., Maleszewski J. J., Suri R. M. et al. CT and MR imaging of the mitral valve: radiologic-pathologic correlation. Radiographics: 2010; 30 603 620
66. Didier D. Assessment of valve disease. Qualitative and quantitative. Magn Reson Imaging Clin N Am: 2003; 11 115 134 (Pubitemid 36384078)
67. Health Canada Congenital Anomalies in Canada - A Perinatal Health Report. Minister of Public Works and Government Services Canada: 2002; http://www.phac-aspc.gc.ca/publicat/cac-acc02/index-eng.php
68. Marelli A. J., Mackie A. S., Ionescu-Ittu R. et al. Congenital heart disease in the general population: Changing prevalence and age distribution. Circulation: 2007; 115 163 172 (Pubitemid 46105714)
69. Freeman L. J. Grown up congenital heart (GUCH) disease: a half century of change. Clinical medicine: 2008; 8 169 171 (Pubitemid 351579201)
70. Kilner P. J., Geva T., Kaemmerer H. et al. Recommendations for cardiovascular magnetic resonance in adults with congenital heart disease from the respective working groups of the European Society of Cardiology. European Heart J: 2010; 3 794 805
71. Kersting-Sommerhoff B. A., Diethelm L., Stanger P. et al. Evaluation of complex congenital ventricular anomalies with magnetic resonance imaging. Am Heart J: 1990; 120 133 142 (Pubitemid 20210237)
72. Hundley W. G., Li H. F., Lange R. A. et al. Assessment of left-to-right intracardiac shunting by velocity-encoded, phase-difference magnetic resonance imaging. A comparison with oximetric and indicator dilution techniques. Circulation: 1995; 91 2955 2960
73. Rebergen S. A., Chin J. G., Ottenkamp J. et al. Pulmonary regurgitation in the late postoperative follow-up of tetralogy of Fallot. Volumetric quantitation by nuclear magnetic resonance velocity mapping. Circulation: 1993; 92 1123 1132
74. Sommer T., Fehske W., Holzknecht N. et al. Aortic dissection: a comparative study of diagnosis with spiral CT, multiplanar transesophageal echocardiography, and MR imaging. Radiology: 1996; 199 347 352 (Pubitemid 26121978)
75. Fayad Z. A., Nahar T., Fallon J. T. et al. In vivo magnetic resonance evaluation of atherosclerotic plaques in the human thoracic aorta: a comparison with transesophageal echocardiography. Circulation: 2000; 101 2503 2509 (Pubitemid 30366255)
76. Steffens J. C., Bourne M. W., Sakuma H. et al. Quantification of collateral blood flow in coarctation of the aorta by velocity encoded cine magnetic resonance imaging. Circulation: 1994; 90 937 943 (Pubitemid 24242765)
77. Wieben O., Francois C., Reeder S. B. Cardiac MRI of ischemic heart disease at 3 T: potential and challenges. Eur J Radiol: 2008; 65 15 28
78. Oshinski J. N., Delfino J. G., Sharma P. et al. Cardiovascular magnetic resonance at 3.0 T: current state of the art. J Cardiovasc Magn Reson: 2010; 12 55 68
79. Schär M., Kozerke S., Fischer S. E. et al. Cardiac SSFP imaging at 3 Tesla. Magn Reson Med: 2004; 51 799 806 (Pubitemid 38420458)
80. Greiser A., Weber O., Deshpande V. et al. Improved cardiac shimming in a clinical setting by multi-frame fieldmap acquisition and automatic ROI extension. J Cardiovasc Magn Reson: 2007; 9 239 240
81. Wansapura J., Fleck R., Crotty E. et al. Frequency scouting for cardiac imaging with SSFP at 3 Tesla. Pediatr Radiol: 2006; 36 1082 1085 (Pubitemid 44377862)
82. Michaely H. J., Nael K., Schoenberg S. O. et al. Analysis of cardiac function - comparison between 1.5 Tesla and 3.0 Tesla cardiac cine magnetic resonance imaging: preliminary experience. Invest Radiol: 2006; 41 133 140 (Pubitemid 44406210)
83. Hudsmith L. E., Cheng A. S., Tyler D. J. et al. Assessment of left atrial volumes at 1.5 Tesla and 3 Tesla using FLASH and SSFP cine imaging. J Cardiovasc Magn Reson: 2007; 9 673 679 (Pubitemid 46956902)
84. Maroules C. D., McColl R., Khera A. et al. Interstudy reproducibility of SSFP cine magnetic resonance: impact of magnetic field strength and parallel imaging. J Magn Reson Imaging: 2008; 27 1139 1145 (Pubitemid 351614628)
85. Cheng A. S., Pegg T. J., Karamitsos T. D. et al. Cardiovascular magnetic resonance perfusion imaging at 3-tesla for the detection of coronary artery disease: a comparison with 1. 5-Tesla. J Am Coll Cardiol: 2007; 49 2440 2449 (Pubitemid 46962268)
86. Hamon M., Fau G., Née G. et al. Meta-analysis of the diagnostic performance of stress perfusion cardiovascular magnetic resonance for detection of coronary artery disease. J Cardiovasc Magn Reson: 2010; 12 29 39
87. Levine G. N., Gomes A. S., Arai A. E. et al. American Heart Association Committee on Diagnostic and Interventional Cardiac Catheterization; American Heart Association Council on Clinical Cardiology; American Heart Association Council on Cardiovascular Radiology and Intervention. Safety of magnetic resonance imaging in patients with cardiovascular devices: an American Heart Association scientific statement from the Committee on Diagnostic and Interventional Cardiac Catheterization, Council on Clinical Cardiology, and the Council on Cardiovascular Radiology and Intervention: endorsed by the American College of Cardiology Foundation, the North American Society for Cardiac Imaging, and the Society for Cardiovascular Magnetic Resonance. Circulation: 2007; 116 2878 2891
88. Strach K., Naehle C. P., Mühlsteffen A. et al. Low field magnetic resonance imaging: increased safety for pacemaker patients? Europace: 2009; 12 952 960
89. Naehle C. P., Kreuz J., Strach K. et al. Safety, feasibility, and diagnostic value of cardiac magnetic resonance imaging in patients with cardiac pacemakers and implantable cardioverters/defibillators at 1.5T. Am Heart J: 2011; 161 1096 1105
90. Rouguin A., Schwitter J., Vahlhaus C. et al. Magnetic resonance imaging in individuals with cardiovascular implantable electronic devices. Europace: 2008; 10 336 346 (Pubitemid 351773738)
91. Sutton R., Kanal E., Wilkoff B. L. et al. Safety of magnetic resonance imaging of patients with a new Medtronic EnRhythm MRISureScan pacing system: clinical study design. Trials: 2008; 9 68 76
92. Shellock F. G. Reference Manual for Magnetic Resonance Safety, Implants, and Devices 2011. Los Angeles Biomedical Research Publishing Group